drugset / Trial / NCT01150461

Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy

NCT01150461

Phase 2 Completed 20 enrolled Massachusetts General Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether taking losartan helps people with hypertrophic nonobstructive cardiomyopathy feel better by decreasing the amount of heart muscle thickening and/or the amount of heart muscle scarring.

Timeline

Start
2007-02
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified 50 mg